市场调查报告书

血小板凝集设备的全球市场 - 成长,趋势,预测(2018年~2023年)

Platelet Aggregation Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 708603
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
Back to Top
血小板凝集设备的全球市场 - 成长,趋势,预测(2018年~2023年) Platelet Aggregation Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日内容资讯: 英文 120 Pages
简介

全球血小板凝集设备市场在2018年到2023年间,预测将以约19%的年复合成长率扩大。

本报告提供血小板凝集设备的全球市场调查,提供市场概要,各类型,用途,终端用户,各地区的市场趋势,市场规模的变化与预测,市场促进·阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要

  • 市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 买方议价能力
    • 产业内的竞争
    • 替代品的威胁
    • 新加入厂商的威胁

第6章 市场动态

  • 成长要素
  • 阻碍因素
  • 市场机会
  • 课题

第7章 市场区隔

  • 各产品
    • 系统
    • 试剂
    • 消耗品·配件
  • 各用途
    • 临床
    • 研究
  • 各终端用户
    • 医院
    • 诊断实验室
    • 研究机关·学术机构
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东·非洲
    • 南美

第8章 企业简介

  • Accriva Diagnostics Holdings Inc.
  • Aggredyne Inc.
  • Bio/Data Corporation
  • F. Hoffman-La Roche Ltd.
  • Haemonetics Corporation
  • Helena Laboratories Corporation
  • Sentinel Ch. SPA
  • Siemens AG
  • Sysmex Corporation
  • TEM Group

第9章 市场未来展望

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 64152

Traditional aggregometer work on the principle of light transmission. The traditional aggregometer performs light transmission aggregometry (LTA) which was once considered as the gold standard for platelet function testing and is still used for the identification and diagnosis of platelet function defects. Traditional LTA remains the most useful technique for diagnosing a wide variety of platelet defects. Additionally, LTA requires a large sample volume, is time-consuming, and there are many pre-analytical and analytical variables that affect the LTA results. These shortcomings in traditional aggregometry spurred the development and advancement of aggregometry techniques which is widely being adopted in the current market. The platelet function analyzers (PFA) are the result of such developments. The platelet function tests performed through a PFA are automated, rapid and mimics several characteristics of physiologic platelet function, because it is a high shear system. Hence, the advancements in aggregometry are improving the adoption rate of these devices and in turn helping in the market growth.

Key Market Trends

Hospital Segment is Expected to Dominate the Market in the Forecast Years

Based on end user, the market is segmented into hospitals, diagnostic laboratories, and others. The factors attributing to the dominance of this segment are a larger patient pool, availability of skilled technicians, and enhanced healthcare infrastructure across the globe. The rise in patient pool, due to substantial growth in the population suffering from diseases, such as bleeding disorders, cardiovascular diseases, and arthritis, is expected to enhance revenue generations of the hospitals. Furthermore, several benefits offered by hospitals in conducting platelet aggregation testing procedures, the high accessibility, and affordability of hospitals are expected to attract a large patient population. Hence, these factors are expected to fuel market growth in the forecast period.

North America holds the Largest Share in the Platelet Aggregation Devices Market

The North America region holds the largest market share due to strong presence of device manufacturers, large patient population for target diseases, growing number of surgical procedures, and rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis. Additionally, factors like large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders is expected to sustain the market leader status of North America supported by high growth rate.

Competitive Landscape

The market studied is moderately competitive and there are several international companies that are operating in this market. The global players into the platelet aggregation devices market are Aggredyne Inc., Bio/Data Corporation, Chrono-Log Corporation, F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Helena Laboratories Corporation, Sentinel Ch. S.P.A., Siemens AG and WerfenLife, S.A.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Target Diseases
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Technological Advancements in Platelet Aggregometers
  • 4.3 Market Restraints
    • 4.3.1 Dearth of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Systems
    • 5.1.2 Reagents
    • 5.1.3 Consumables and Accessories
  • 5.2 By Application
    • 5.2.1 Clinical Applications
    • 5.2.2 Research Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Laboratories
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aggredyne, Inc.
    • 6.1.2 Bio/Data Corporation
    • 6.1.3 Chrono-Log Corporation
    • 6.1.4 F. Hoffmann-La Roche Ltd
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 Helena Laboratories Corporation
    • 6.1.7 Sentinel Ch. S.P.A.
    • 6.1.8 Siemens AG
    • 6.1.9 WerfenLife, S.A.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top